Itrm stock forecast the ITRM stock forecast currently

The ITRM stock forecast currently factors sector-wide resilience, as biotech indices have rebounded 4.3% month-to-date. Analysts highlight $1.10 as a key support level, making it a critical technical pivot for swing traders. Types: Market News, Top Stocks, Stock Ideas, Investment Strategies, Alpha Picks The most recent analyst rating on (ITRM) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Iterum Therapeutics stock, see the ITRM Stock Forecast page . Based on market screening, the ITRM stock forecast reflects bullish momentum, with institutional accumulation showing in upticks in daily charts. Investors are watching upcoming FDA-related announcements, which could shift price targets rapidly.